Mammalian cell culture systems are starting to dominate the production of vaccines for viral diseases such as rabies. Making use of existing biopharma infrastructure, these advances might even spell the end for the use of hens’ eggs in future vaccine development.
Today, the rapidly expanding demand for vaccine products for viral diseases such as rabies has necessitated the development of more sophisticated production techniques based around cell culture systems. This article reviews vaccine production strategies, with a focus on rabies, looking specifically at the use of the Vero cell line – used worldwide and approved by the US Food and Drug Administration – as well as media technology and the bioreactor options available.
Growing Demand
Viral diseases, including rabies, are worldwide challenges for the international biomedical community. The World Health Organization (WHO) notes that over 32,000 rabies-related deaths were reported in 1998, while annual deaths worldwide from the virus grew to 55,000 by 2006 1,2 .
Rabies is often transmitted to humans from infected domestic animals. Dogs infected with rabies can become extremely aggressive and attacks on humans are widespread, especially in certain Asian countries where using unleashed dogs for home security is common. It is spread through the saliva of infected animals and bites can be fatal.
Since the 18th century, vaccination has proven to be the most successful – and perhaps the only – route to the total elimination of viral diseases such as rabies. From the early work of pioneers such as Jenner and Pasteur, vaccination was put on a sound scientific footing. Demand for vaccine products has continued to increase ever since, prompting the advances in production technology that we see today.
Viral Cultivation
The expanding vaccine requirements have led to techniques for growing large quantities of antigenic proteins. Traditionally, viruses have been grown in embryonated hens’ eggs, but numerous shortcomings compromise their utility. These include a bottleneck in the availability of high-quality, pathogen-free eggs, as well as low titers of emerging viruses 3) .
This story is from the February 2019 edition of Pharma Bio World.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the February 2019 edition of Pharma Bio World.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
More Efficiency, More Communication
B&R has published a new major release of its APROL process control system. APROL R 4.2 contains numerous new software functions, including improved cloud communication via OPC UA and MQTT. It also offers a modern new “Dark style” interface design option.
Phytopharmaceuticals & Their Role In Human Health
Nutraceuticals and functional foods on an average are globally becoming giant players in health sector. In a survey, it was reported that in year 2010 alone, there was a huge market growth of nutraceuticals and food supplements. Phytopharmaceuticals, nutraceuticals and functional foods have the potential to substantially reduce the expensive, high-tech, disease treatment approaches particularly common in developed countries. Charu Gupta and Dhan Prakash from Amity Institute for Herbal Research & Studies explores the world of Phytopharmaceuticals and nutraceuticals in this article.
Bosch Packaging Technology Showcases Laboratory Competence In R&D And Industry 4.0
One of the leading suppliers of process and packaging technology, Bosch Packaging Technologys new laboratory device Xelum R&D for continuous manufacturing is an example of how the Bosch Pharma Service and Industry 4.0 solutions support pharmaceutical manufacturers in increasing transparency and efficiency of their laboratory processes.
ECOFLUX* Corrugated Tube Heat Exchanger
HRS Process Systems Ltd, India, is part of UK-based HRS group of companies, a leading heat transfer technology provider.
WACKER Invests In Jena Biotech Site
The Munich-based chemical group WACKER has enhanced its production facilities for biopharmaceuticals also known as biologics with new equipment.
Unsolved Chronic Wounds Increasing Rapidly In India…
+dalethyne, a path breaking molecule, only one of its kind in the world, invented after 18 years of untiring research since 2000 by K.S. Dharshan, the Founder and Chairman of Indonesia based Dermozone , is all set to revolutionize the wound care market in India. +dalethyne would be the key ingredient of the new Dermozone range of wound care products soon to be launched in India. Mr. K.S. Dharshan, CEO – Dermozone gives us more details in this brief interview with PharmaBio World.
Making Water Safe Through Quick Detection Of Legionella
Legionellosis is a collective term for diseases caused by legionella bacteria including the most serious Legionnaires’ disease, as well as the similar but less serious conditions of Pontiac fever and Lochgoilhead fever.
Solid Dosage: Technologies To Tablet Effervescent Products
Tableting effervescent products is a complex process.
Unmatched Efficiency With High-speed Diverters
B&R presents flexible transport system at Hannover MesseB&R’s new flexible transport system is designed to deliver ultimate production effectiveness – from mass pro-duction down to batches of one. Playing a pivotal role in making this possible are the system’s purely elec-tromagnetic diverters, which are able to divide and merge product flows at full production speed. B&R will be presenting its transport system from April 23-27 at the Hannover Messe in Hall 9, Booth D26.
Digitalization Is Not An Option, But A Must
B&R India explores IIoT topics at 4th annual Innovation Day.